BUZZ-WuXi Biologics falls on US security risk concerns

Reuters05-17

** Shares of WuXi Biologics fall 3.4% to HK$14.06

** Co says it noted that a meeting in relation to a revised version of a draft bill was held by the U.S. House Committee on Oversight and Accountability on May 15

** Says the bill includes co in the proposed definition of the term “biotechnology company of concern”, which it believes is a preemptive and unjustified designation

** Co says it does not have a human genomics business nor does it collect human genomic data in any of its businesses

** Adds it does not and will not pose a security risk to the United States or any other countries

** Hong Kong shares of WuXi AppTec slip 1.6% and Shanghai stock eases 1.5%

** WuXi Biologics is down 52.4% YTD

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment